TipRanks
Go Ultimate55% OFF

Takeda Pharmaceutical Co (0RN3) Cash flow

Takeda Pharmaceutical Co Cash Flow

GB:0RN3's free cash flow for Q2 2026 was $213.19B. For the 2026 fiscal year, GB:0RN3's free cash flow was decreased by $-44.69B and operating cash flow was $257.88B. See a summary of the company’s cash flow.

Cash Flow
Cash FlowMar 26Mar 25Mar 24Mar 23Mar 22
$ 938.71B$ 962.49B$ 640.32B$ 877.22B$ 1.02T
$ -387.80B$ -385.36B$ -488.21B$ -615.72B$ -204.44B
$ -375.44B$ -638.44B$ -254.04B$ -600.59B$ -962.06B
$ 595.05B$ 233.74B$ 205.19B$ 229.56B$ 849.70B
$ 762.71B$ 761.70B$ 464.90B$ 736.56B$ 897.97B

Currency in JPY

Takeda Pharmaceutical Co Cash Flow

-4T-2T02T4T201720182019202020212022202320242025OperatingInvestingFinancing